The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases
- PMID: 37032353
- PMCID: PMC10325998
- DOI: 10.1038/s41431-023-01350-8
The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases
Conflict of interest statement
VF-B manages a genetic testing facility that uses MLPA in the diagnosis of aHUS. The other authors declare no competing interests.
Figures


Comment on
-
The complete sequence of a human genome.Science. 2022 Apr;376(6588):44-53. doi: 10.1126/science.abj6987. Epub 2022 Mar 31. Science. 2022. PMID: 35357919 Free PMC article.
References
-
- Detection of genetic rearrangements in the regulators of complement activation RCA cluster by high-throughput sequencing and MLPA | SpringerLink [Internet]. [cited 2021 Oct 23]. Available from: https://link.springer.com/protocol/10.1007/978-1-0716-1016-9_16. - DOI - PubMed
-
- Abarrategui-Garrido C, Martínez-Barricarte R, López-Trascasa M, de Córdoba SR, Sánchez-Corral P. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood. 2009;114:4261–71. doi: 10.1182/blood-2009-05-223834. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases